BioSpace News Archive

Press Releases

Ivonescimab Shows Quality of Life Benefits in Chemotherapy-Free First-Line NSCLC: Health-Related Quality of Life Data from the HARMONi-2 Study Presented at ELCC 2026

March 31, 2026
·
6 min read
Press Releases

AviadoBio Advances AVB-101 Gene Therapy Program and Initiates Fourth Dose-Escalation Cohort of Phase 1/2 ASPIRE-FTD Trial

March 31, 2026
·
5 min read
Press Releases

Signadori Bio appoints Dr. Selwyn Ho, MB BS as Chief Executive Officer to lead company into next stage of growth

March 31, 2026
·
5 min read
Press Releases

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 31, 2026

March 31, 2026
·
4 min read
Press Releases

BioInvent International AB Publishes Annual Report 2025

March 31, 2026
·
5 min read
Press Releases

Broken String Biosciences Rebrands to Reflect Strategic Evolution as Demand Grows for Unbiased Genome-wide Off-target Analysis

March 31, 2026
·
3 min read
Press Releases

Semarion Secures $3.8 Million to Scale Next-Generation Cell Assay Technology and Accelerate Pharma Adoption

March 31, 2026
·
3 min read
Press Releases

SignateraTM MRD Identifies Breast Cancer Patients Who Can Forgo Surgery

March 31, 2026
·
3 min read
Press Releases

Keenova Announces Unaudited Fourth Quarter 2025 Financial Results

March 31, 2026
·
21 min read
Press Releases

SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

March 31, 2026
·
7 min read